Predictive Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1.62	1.63	1.51	1.42	1.25	Upgrade
Revenue Growth (YoY)	-0.24%	8.12%	5.97%	13.45%	-11.29%	Upgrade
Cost of Revenue	0.83	0.61	0.51	0.49	0.45	Upgrade
Gross Profit	0.8	1.02	1	0.93	0.81	Upgrade
Selling, General & Admin	11.74	13.14	16.27	14.41	13.29	Upgrade
Operating Expenses	11.74	13.14	16.27	14.41	13.29	Upgrade
Operating Income	-10.94	-12.12	-15.27	-13.47	-12.48	Upgrade
Other Non Operating Income (Expenses)	0.08	0.1	0.31	0.12	-0.36	Upgrade
EBT Excluding Unusual Items	-10.86	-12.02	-14.96	-13.36	-12.84	Upgrade
Impairment of Goodwill	-	-	-7.23	-2.81	-12.88	Upgrade
Gain (Loss) on Sale of Assets	-0	-0	-0.01	-0.01	-	Upgrade
Asset Writedown	-	-	-3.53	-4.14	-	Upgrade
Other Unusual Items	-	-	-	-	-0.16	Upgrade
Pretax Income	-10.86	-12.02	-25.74	-20.32	-25.88	Upgrade
Income Tax Expense	-	-	-	-0.66	-	Upgrade
Earnings From Continuing Operations	-10.86	-12.02	-25.74	-19.66	-25.88	Upgrade
Earnings From Discontinued Operations	-1.8	-1.97	-	-	-	Upgrade
Net Income	-12.66	-13.98	-25.74	-19.66	-25.88	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	0.55	Upgrade
Net Income to Common	-12.66	-13.98	-25.74	-19.66	-26.44	Upgrade
Shares Outstanding (Basic)	5	4	4	3	1	Upgrade
Shares Outstanding (Diluted)	5	4	4	3	1	Upgrade
Shares Change (YoY)	35.84%	8.92%	34.34%	359.21%	316.36%	Upgrade
EPS (Basic)	-2.32	-3.48	-6.98	-7.16	-44.25	Upgrade
EPS (Diluted)	-2.32	-3.48	-6.98	-7.20	-44.25	Upgrade
Free Cash Flow	-11.97	-13.21	-12.79	-13.12	-12.56	Upgrade
Free Cash Flow Per Share	-2.19	-3.29	-3.47	-4.78	-21.01	Upgrade
Gross Margin	49.12%	62.57%	66.45%	65.72%	64.29%	Upgrade
Operating Margin	-673.69%	-744.47%	-1014.16%	-948.25%	-996.87%	Upgrade
Profit Margin	-779.91%	-859.13%	-1709.62%	-1383.64%	-2111.26%	Upgrade
Free Cash Flow Margin	-736.86%	-811.63%	-849.62%	-923.46%	-1002.67%	Upgrade
EBITDA	-10.78	-11.87	-13.95	-12.13	-11.46	Upgrade
D&A For EBITDA	0.16	0.24	1.31	1.34	1.02	Upgrade
EBIT	-10.94	-12.12	-15.27	-13.47	-12.48	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q